HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jennifer R Verani Selected Research

COVID-19 Vaccines

5/2022Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant - United States, February 14-March 27, 2022.
2/2022Clinical Severity and mRNA Vaccine Effectiveness for Omicron, Delta, and Alpha SARS-CoV-2 Variants in the United States: A Prospective Observational Study.
1/2022Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.
12/2021Comparative Effectiveness and Antibody Responses to Moderna and Pfizer-BioNTech COVID-19 Vaccines among Hospitalized Veterans - Five Veterans Affairs Medical Centers, United States, February 1-September 30, 2021.
11/2021Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity.
11/2021Laboratory-Confirmed COVID-19 Among Adults Hospitalized with COVID-19-Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity - Nine States, January-September 2021.
10/2021Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings.
9/2021Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions - United States, March-August 2021.
8/2021Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.
8/2021Effectiveness of COVID-19 Vaccines in Preventing Hospitalization Among Adults Aged ≥65 Years - COVID-NET, 13 States, February-April 2021.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jennifer R Verani Research Topics

Disease

36COVID-19
10/2022 - 04/2020
16Infections
10/2022 - 01/2015
10Pneumonia (Pneumonitis)
01/2022 - 07/2013
8Pneumococcal Infections
01/2021 - 06/2014
4Diarrhea
11/2020 - 01/2018
4Human Influenza (Influenza)
10/2020 - 01/2016
4Gastroenteritis
01/2020 - 05/2015
3Malaria
01/2022 - 07/2015
3Sepsis (Septicemia)
01/2022 - 01/2016
2Cough
11/2019 - 01/2017
2Pneumococcal Pneumonia
11/2019 - 01/2015
2Bacterial Pneumonia
11/2016 - 12/2015
2Acanthamoeba Keratitis
01/2016 - 08/2009
2Hypersensitivity (Allergy)
08/2013 - 11/2010
1Thrombocytopenia (Thrombopenia)
04/2022
1Thrombosis (Thrombus)
04/2022
1Communicable Diseases (Infectious Diseases)
01/2022
1Central Nervous System Infections (Central Nervous System Infection)
01/2022
1Soft Tissue Infections
01/2022
1Disease Progression
11/2021
1Malnutrition (Nutritional Deficiencies)
01/2020
1Chest Pain (Chest Pains)
11/2019
1Bacterial Infections (Bacterial Infection)
05/2019
1Dysentery
05/2019
1Bacteremia
01/2018
1Stillbirth
12/2017
1Meningitis
12/2017
1Neonatal Sepsis
12/2017
1Fever (Fevers)
01/2017
1Respiratory Tract Infections (Respiratory Tract Infection)
11/2016
1Eye Diseases (Eye Disease)
01/2016
1Schistosomiasis (Bilharziasis)
01/2011
1Premature Obstetric Labor (Premature Labor)
11/2010
1Rupture
11/2010
1Chagas Disease (American Trypanosomiasis)
03/2009

Drug/Important Bio-Agent (IBA)

39VaccinesIBA
08/2022 - 05/2015
22mRNA VaccinesIBA
10/2022 - 07/2021
16Messenger RNA (mRNA)IBA
08/2022 - 08/2021
11BNT162 VaccineIBA
08/2022 - 03/2021
11COVID-19 VaccinesIBA
05/2022 - 05/2021
10Conjugate VaccinesIBA
01/2021 - 07/2013
62019-nCoV Vaccine mRNA-1273IBA
08/2022 - 08/2021
5Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 07/2015
5AntigensIBA
01/2021 - 03/2009
510-valent pneumococcal conjugate vaccineIBA
01/2021 - 06/2014
2Neutralizing AntibodiesIBA
04/2022 - 01/2022
2Ad26COVS1IBA
03/2022 - 10/2021
2AntibodiesIBA
01/2022 - 01/2022
2Immunoglobulin G (IgG)IBA
12/2021 - 09/2021
2Influenza Vaccines (Influenza Vaccine)FDA Link
10/2020 - 10/2020
2Rotavirus VaccinesIBA
01/2020 - 01/2020
2C-Reactive ProteinIBA
11/2016 - 12/2015
2Penicillins (Penicillin)FDA Link
08/2013 - 11/2010
1N-methyl-valyl-amiclenomycin (BA 2)IBA
05/2022
1COVID-19 vaccine booster shotIBA
04/2022
1Nucleic AcidsIBA
11/2021
1insulin receptor-related receptor (IRR)IBA
01/2021
1DNA (Deoxyribonucleic Acid)IBA
01/2020
1Ciprofloxacin (Cipro)FDA LinkGeneric
05/2019
1Pharmaceutical PreparationsIBA
01/2018
1Virulence Factors (Pathogenicity Factors)IBA
01/2018
1Tobacco Smoke Pollution (Passive Smoking)IBA
11/2016
1ORALIT (ORS)IBA
01/2016
1Complement System Proteins (Complement)IBA
01/2016
1CarbonIBA
01/2011
1Penicillin G (Benzylpenicillin)FDA LinkGeneric
11/2010
1Contact Lens Solutions (Contact Lens Solution)IBA
08/2009

Therapy/Procedure

5Ambulatory Care (Outpatient Care)
04/2022 - 05/2019
3Home Nursing (Nursing, Home)
05/2022 - 08/2021
2Long-Term Care
08/2021 - 03/2021
1Artificial Respiration (Mechanical Ventilation)
11/2021
1Nebulizers and Vaporizers (Inhaler)
04/2020
1Personal Protective Equipment
04/2020
1Therapeutics
05/2019
1Contact Lenses
01/2016
1Chemoprevention
11/2010